Post-Marketing Surveillance of Adverse Events Following Vaccination with the Live-Attenuated Japanese Encephalitis Chimeric Virus Vaccine (Imojev®) in South Korea, 2015–2019
Crossref DOI link: https://doi.org/10.1007/s40121-020-00305-6
Published Online: 2020-05-30
Published Print: 2020-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kim, Hee Soo
Oh, Yongho
Korejwo, Joanna
Castells, Valérie Bosch
Yang, Kuhyun
Funding for this research was provided by:
Sanofi Pasteur
Article History
Received: 16 April 2020
First Online: 30 May 2020